These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8510490)
1. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon. de Alava E; Camps J; Pardo-Mindán J; García-Granero M; Muñoz M; Sola J; Civeira MP; Contreras F; Vázquez JJ; Castilla A Liver; 1993 Apr; 13(2):73-9. PubMed ID: 8510490 [TBL] [Abstract][Full Text] [Related]
2. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection. Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073 [TBL] [Abstract][Full Text] [Related]
3. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course. Reichard O; Glaumann H; Norkrans G; Wejstål R; Fryden A; Schvarcz R; Weiland O Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108 [TBL] [Abstract][Full Text] [Related]
4. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis. Cammà C; Giunta M; Linea C; Pagliaro L J Hepatol; 1997 Jun; 26(6):1187-99. PubMed ID: 9210603 [TBL] [Abstract][Full Text] [Related]
5. Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response. Reichard O; Glaumann H; Weiland O Scand J Infect Dis; 1994; 26(4):383-9. PubMed ID: 7984968 [TBL] [Abstract][Full Text] [Related]
7. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. Shiffman ML; Hofmann CM; Thompson EB; Ferreira-Gonzalez A; Contos MJ; Koshy A; Luketic VA; Sanyal AJ; Mills AS; Garrett CT Hepatology; 1997 Sep; 26(3):780-5. PubMed ID: 9303513 [TBL] [Abstract][Full Text] [Related]
8. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. Camps J; García-Granero M; Riezu-Boj JI; Larrea E; de Alava E; Civeira MP; Castilla A; Prieto J J Hepatol; 1994 Jul; 21(1):4-11. PubMed ID: 7963420 [TBL] [Abstract][Full Text] [Related]
9. Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. Camps J; Castilla A; Ruiz J; Civeira MP; Prieto J J Hepatol; 1993 Mar; 17(3):390-6. PubMed ID: 8391042 [TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up. Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298 [TBL] [Abstract][Full Text] [Related]
11. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C. Ziol M; Nhieu JT; Roudot-Thoraval F; Métreau JM; Deugnier Y; Dhumeaux D; Zafrani ES J Hepatol; 1996 Dec; 25(6):833-41. PubMed ID: 9007710 [TBL] [Abstract][Full Text] [Related]
17. Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses. Picciotto A; Callea F; Varagona G; Bardellini E; Borzone S; De Conca V; Vallarino E; Giudici-Cipriani A; Vitali A; Grasso A Liver; 1995 Feb; 15(1):20-4. PubMed ID: 7776853 [TBL] [Abstract][Full Text] [Related]
18. Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C. Panella C; Francavilla A; Conte D; Tatulli I; Rubini F Gut; 1993; 34(2 Suppl):S127. PubMed ID: 8314478 [TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis D with interferon alfa-2a. Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188 [TBL] [Abstract][Full Text] [Related]
20. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment]. Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]